摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-isopropyl-4-methyl-2-pentenoic acid | 97307-93-2

中文名称
——
中文别名
——
英文名称
3-isopropyl-4-methyl-2-pentenoic acid
英文别名
4-methyl-3-(isopropyl)-pent-2-enoic acid;3-isopropyl-4-methyl-pent-2-enoic acid;3-Isopropyl-4-methyl-pent-2-ensaeure;4-Methyl-3-propan-2-ylpent-2-enoic acid
3-isopropyl-4-methyl-2-pentenoic acid化学式
CAS
97307-93-2
化学式
C9H16O2
mdl
——
分子量
156.225
InChiKey
MQJHHPDMPRCFOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
    申请人:Millennium Pharmaceuticals, Inc.
    公开号:US20160031908A1
    公开(公告)日:2016-02-04
    Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
    揭示了新颖的化合物以及治疗与异常白细胞召集和/或激活相关的疾病的方法。该方法包括向需要的受试者施用代表的化合物的有效量: 或其生理上可接受的盐。
  • Quassinoid compositions for the treatment of cancer and other proliferative diseases
    申请人:McChesney D. James
    公开号:US20060281807A1
    公开(公告)日:2006-12-14
    The invention provides quassinoid compounds that are useful in treating cancer. The invention further provides a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, a method of killing a cancer cell, and a method of treating cancer in a mammal.
    这项发明提供了对治疗癌症有用的苦木酮类化合物。该发明还提供了一种包含药用载体和该发明中至少一种化合物的组合物,一种杀死癌细胞的方法,以及一种治疗哺乳动物癌症的方法。
  • CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR
    申请人:Luly Jay R.
    公开号:US20090281081A1
    公开(公告)日:2009-11-12
    Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
    本发明涉及新化合物以及一种治疗与异常白细胞招募和/或激活相关的疾病的方法。该方法包括向需要治疗的受体内给予一种有效量的化合物,该化合物表示为:或其生理上可接受的盐。
  • Chemokine receptor antagonists and methods of use therefor
    申请人:Luly R. Jay
    公开号:US20070060592A1
    公开(公告)日:2007-03-15
    Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
    本发明涉及一种新型化合物和一种治疗与异常白细胞招募和/或激活相关的疾病的方法。该方法包括向需要治疗的受体内投与有效量的化合物,所述化合物的表示式为:或其生理上可接受的盐。
  • Slipping property imparting agent for clear coating and clear coating paper having the agent applied thereon
    申请人:Ono Hiroshi
    公开号:US20050176908A1
    公开(公告)日:2005-08-11
    Produce a slipping property imparting agent for clear coat that reduces scum production: wherein, (1) the agent comprises a copolymer whose constituents are unsaturated olefin (constituent (a)) and unsaturated carboxylic acid (carboxylate) (constituent (b)); (2) constituent (a) accounts for 50 to 99 mol percent and constituent (b) accounts for 50 to 1 mol percent, respectively, of the total mol number of constituents (a) and (b) combined; and (3) a constituent (c) that can be polymerized with the constituents (a) and (b) is contained, as necessary, by up to 20 mol percent of the total mol number of constituents (a) and (b) combined.
    生产一种可减少浮渣产生的透明涂层滑爽性赋予剂:其中,(1)该剂包括一种共聚物,其成分为不饱和烯烃(成分(a))和不饱和羧酸(羧酸盐)(成分(b));(2)成分(a)分别占成分(a)和(b)总和摩尔数的50%至99%,成分(b)分别占50%至1%;(3) 可与成分(a)和(b)聚合的成分(c)必要时最多占成分(a)和(b)总摩尔数的 20%。
查看更多